Is Curcumin an Antidote for Civilization Diseases? A Literature Review
DOI:
https://doi.org/10.12775/QS.2024.35.56290Keywords
curcumin, diabetes mellitus type 2, Obesity,, glucose, lipids, Cardiovascular diseaseAbstract
Introduction and purpose: Curcumin is the main natural lipophilic polyphenol obtained from Curcuma longa L. Its anti-inflammatory, anti-cancerous, anti-obesity, antioxidant, and lipid-lowering effects have attracted scientists' attention. Due to its diverse pharmacological properties, curcumin might be a beneficial and promising nutraceutical food dealing with civilization diseases. NCDs (non-communicable diseases) such as obesity, cardiovascular diseases, and diabetes mellitus are significant health issues affecting global society.
Aim of the study: The purpose of this review is to present a thorough analysis of the impact of supplementation curcumin on the prevention, course, and complications of obesity, cardiovascular diseases, and diabetes mellitus.
Material and methods: An analysis of papers available in PubMed and Google Scholar was performed using the following keywords: curcumin, curcumin and Type 2 Diabetes Mellitus, curcumin and chronic diseases, curcumin and obesity, curcumin and Cardiovascular diseases, curcumin and lipid, curcumin and glucose.
Conclusion: As studies have shown, curcumin might be a promising nutraceutical food in treating obesity, cardiovascular diseases, and type 2 diabetes mellitus. Further research should be conducted to assess the impact of curcumin better and to establish the appropriate dose, formulation, and duration of the therapy.
References
Jin, Tr. Curcumin and dietary polyphenol research: beyond drug discovery. Acta Pharmacol Sin 39, 779–786 (2018). https://doi.org/10.1038/aps.2017.179
Kocaadam B, Şanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017 Sep 2;57(13):2889-2895. doi: 10.1080/10408398.2015.1077195. PMID: 26528921
Menon, Venugopal P., and Adluri Ram Sudheer. ‘Antioxidant and Anti-Inflammatory Properties of Curcumin’. Advances in Experimental Medicine and Biology 595 (2007): 105–25. https://doi.org/10.1007/978-0-387-46401-5_3
Budreviciute A, Damiati S, Sabir DK, Onder K, Schuller-Goetzburg P, Plakys G, Katileviciute A, Khoja S and Kodzius R (2020) Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors. Front. Public Health 8:574111. doi: 10.3389/fpubh.2020.574111
Chooi, Yu Chung, Cherlyn Ding, and Faidon Magkos. ‘The Epidemiology of Obesity’. Metabolism, Obesity: the 21st century epidemic, 92 (1 March 2019): 6–10. https://doi.org/10.1016/j.metabol.2018.09.005.
World Health Organization. Obesity and overweight. Fact sheet no 311 January 2015. [cited 21.04.2024; Available from] http://www.who.int/ mediacentre/factsheets/fs311/en
Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, et al. (2013) The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis. PLoS ONE 8(7): e65174. https://doi.org/10.1371/journal.pone.0065174
Czernichow S, Kengne AP, Stamatakis E, Hamer M, Batty GD. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies. Obes Rev. 2011 Sep;12(9):680-7. doi: 10.1111/j.1467-789X.2011.00879.x. Epub 2011 Apr 27. PMID: 21521449; PMCID: PMC4170776.
Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K; International Agency for Research on Cancer Handbook Working Group. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016 Aug 25;375(8):794-8. doi: 10.1056/NEJMsr1606602. PMID: 27557308; PMCID: PMC6754861.
Yueshui Zhao, Bo Chen, Jing Shen, Lin Wan, Yinxin Zhu, Tao Yi, Zhangang Xiao, "The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity", Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 1459497, 8 pages, 2017. https://doi.org/10.1155/2017/1459497
Varì R, Scazzocchio B, Silenzi A, Giovannini C, Masella R. Obesity-Associated Inflammation: Does Curcumin Exert a Beneficial Role? Nutrients. 2021 Mar;13(3):1021.
Schwartz B, Yehuda-Shnaidman E. Putative Role of Adipose Tissue in Growth and Metabolism of Colon Cancer Cells. Frontiers in Oncology [Internet]. 2014;4.
Akbari M, Lankarani KB, Tabrizi R, Ghayour-Mobarhan M, Peymani P, Ferns G, et al. The Effects of Curcumin on Weight Loss Among Patients With Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Pharmacol 2019 Jun 12
Azhdari M, Karandish M, Mansoori A. Metabolic benefits of curcumin supplementation in patients with metabolic syndrome: A systematic review and meta‐analysis of randomized controlled trials. Phytotherapy Research. 2019 May;33(5):1289–301.
Mousavi SM, Milajerdi A, Varkaneh HK, Gorjipour MM, Esmaillzadeh A. The effects of curcumin supplementation on body weight, body mass index and waist circumference: a systematic review and dose-response meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition. 2020 Jan 2;60(1):171–80.
Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, Qorbani M, Alavian SM, Daneshi-Maskooni M, et al. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial. Nutr Metab (Lond). 2019 Jan 28;16(1):8.
Saraf‐Bank S, Ahmadi A, Paknahad Z, Maracy M, Nourian M. Effects of curcumin supplementation on markers of inflammation and oxidative stress among healthy overweight and obese girl adolescents: A randomized placebo‐controlled clinical trial. Phytotherapy Research. 2019 Aug;33(8):2015–22.
Qin S, Huang L, Gong J, Shen S, Huang J, Ren H, et al. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutr J. 2017 Oct 11;16(1):68.
Campbell MS, Ouyang A, I.m. K, Charnigo RJ, Westgate PM, Fleenor BS. Influence of enhanced bioavailable curcumin on obesity-associated cardiovascular disease risk factors and arterial function: A double-blinded, randomized, controlled trial. Nutrition. 2019 Jun 1;62:135–9.
Azhdari M, Karandish M, Mansoori A. Metabolic benefits of curcumin supplementation in patients with metabolic syndrome: A systematic review and meta‐analysis of randomized controlled trials. Phytotherapy Research. 2019 May;33(5):1289–301.
Hadi A, Pourmasoumi M, Ghaedi E, Sahebkar A. The effect of Curcumin/Turmeric on blood pressure modulation: A systematic review and meta-analysis. Pharmacological Research. 2019 Dec;150:104505.
Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017 Mar 14;38(11):774–84. 1.
Grech E D, Jackson M J, Ramsdale D R. Reperfusion injury after acute myocardial infarction BMJ 1995; 310 :477 doi:10.1136/bmj.310.6978.477
Wongcharoen W, Jai-aue S, Phrommintikul A, Nawarawong W, Woragidpoonpol S, Tepsuwan T, et al. Effects of Curcuminoids on Frequency of Acute Myocardial Infarction After Coronary Artery Bypass Grafting. The American Journal of Cardiology. 2012 Jul;110(1):40–4.
Aslanabadi N, Entezari-Maleki T, Rezaee H, Jafarzadeh HR, Vahedpour R. Curcumin for the prevention of myocardial injury following elective percutaneous coronary intervention; a pilot randomized clinical trial. European Journal of Pharmacology. 2019 Sep;858:172471.
Phrommintikul A, Chanchai R, Wongcharoen W. Effects of Curcuminoids on Myocardial Injury After Percutaneous Coronary Intervention. Journal of Medicinal Food. 2019 Jul;22(7):680–4.
Pivari F, Mingione A, Brasacchio C, Soldati L. Curcumin and Type 2 Diabetes Mellitus: Prevention and Treatment. Nutrients. 2019 Aug 8;11(8):1837.
Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. Curcumin Extract for Prevention of Type 2 Diabetes. Diabetes Care. 2012 Nov 1;35(11):2121–7.
Thota RN, Acharya SH, Garg ML. Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial. Lipids Health Dis. 2019 Dec;18(1):31.
Farmaki P, Damaskos C, Garmpis N, Garmpi A, Savvanis S, Diamantis E. Complications of the Type 2 Diabetes Mellitus. Curr Cardiol Rev. 2020 Nov;16(4):249–51.
Asadi S, Gholami MS, Siassi F, Qorbani M, Khamoshian K, Sotoudeh G. Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial. Complementary Therapies in Medicine. 2019 Apr;43:253–60.
Adibian M, Hodaei H, Nikpayam O, Sohrab G, Hekmatdoost A, Hedayati M. The effects of curcumin supplementation on high‐sensitivity C‐reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial. Phytotherapy Research. 2019 May;33(5):1374–83.
Mokhtari M, Razzaghi R, Momen‐Heravi M. The effects of curcumin intake on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double‐blind, placebo‐controlled trial. Phytotherapy Research. 2021 Apr;35(4):2099–107.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Adrianna Madej, Adrian Suława, Oskar Targoński, Marta Targońska, Julia Furgalska-Kudła , Sebastian Fedorowicz, Aneta Basiak, Aleksander Ptasiński , Rafał Niekurzak, Agnieszka Buczek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 1
Number of citations: 0
